Table: begin end state 1 8 cytoplasmic 9 26 transmembrane 27 31 non-cytoplasmic 32 50 transmembrane 51 60 cytoplasmic 61 80 transmembrane 81 107 non-cytoplasmic 108 136 transmembrane 137 143 cytoplasmic 144 162 transmembrane 163 181 non-cytoplasmic 182 209 transmembrane 210 229 cytoplasmic 230 249 transmembrane 250 268 non-cytoplasmic 269 288 transmembrane 289 299 cytoplasmic 300 323 transmembrane 324 338 non-cytoplasmic 339 358 transmembrane 359 364 cytoplasmic 365 384 transmembrane 385 389 non-cytoplasmic 390 413 transmembrane 414 424 cytoplasmic 425 449 transmembrane 450 450 non-cytoplasmic
Input: >GFF4292 FitnessBrowser__WCS417:GFF4292 MFGMSHESYLLLDAVVTIIGLIVLITKFKVHPFIALIIAAGFLGLTSGMPVDKIIKAFQD GFGGVLGFVGIILALGTMLGKMMAESGGADQIAQTLIRAFGKEKVQWAMMFAAFLVGIPL FFEIGFVLLIPLVFIVARRTGVSLIKIGIPLLAGLSAVHGLVPPHPGPLLAIGVFGADIG KTILYGLIVALPTAIIAGPIFGTFIAKYIPGNPSQELVDQLARETDNKSLPSFGITLVTV LLPVFLMLLKTFADIAFAEGNVVRNWMDMIGHPITALLLALLLSLYTFGHRQGIHSKQIL KLLDASLAPTAAIILIIGAGGGFKQMLVTSGVGDVIGHMAVNAQINPILLAWLVAAVIRV ATGSATVATITGAGIVVPVVGMIPGVNRELLVLATGAGSLILSHVNDAGFWLVKQYFNMT VAETFKTWTAMETILSVVALIFIMLLSLVV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server